US › Healthcare

EDAP TMS S.A. (FOCL)

US · Healthcare · Medical Distribution

$4.28+5.16%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$13.2M

Revenue YoY

-27.5%

Net profit

$-14.5M

EPS

$-0.24

EPS estimate

$-0.20

Net margin

-109.7%

EPS came in at -0.24 against a street estimate of -0.20 — a miss of 20.0%.

Key statistics

Market cap

$156.1M

Forward P/E

38.9

P/B

17.22

Book value

$-0.09

EPS (TTM)

$-1.04

52-week high

$6.40

52-week low

$1.75

50-day MA

$5.18

200-day MA

$4.17

Beta

-0.07

Analyst view

with an average price target of $8.60.

Shareholding

Insiders

5.11%

Institutions

31.32%

Largest institutional holders

Fund	Stake
Soleus Capital Management, L.P.	19.48%
Morgan Stanley - Brokerage Accounts	8.91%
Rock Springs Capital Management LP	3.69%
FLAX POND CAPITAL, LLC	2.09%
Bruce & Co Inc	1.17%
UBS Group AG	0.45%
Parkman Healthcare Partners LLC	0.41%
Essex Investment Management Company, LLC	0.39%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for EDAP TMS S.A. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.